Ana B Rodríguez

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Cell Cycle Arrest

Top Venues

Laboratory animals

This page only lists publications with an associated author ORCID identifier.

Publications

José C Bravo, Lierni Ugartemendia, Arko Barman, Ana B Rodríguez, José A Pariente, Rafael Bravo
Bibliometric analysis on cannibalism/infanticide and maternal aggression towards pups in laboratory rodents. Laboratory animals (2024)
José C Bravo, Lierni Ugartemendia, Arko Barman, Ana B Rodríguez, José A Pariente, Rafael Bravo
Bibliometric analysis on cannibalism/infanticide and maternal aggression towards pups in laboratory rodents. Laboratory animals 58 (3) (2024)
José C Bravo, Lierni Ugartemendia, Arko Barman, Ana B Rodríguez, José A Pariente, Rafael Bravo
Bibliometric analysis on cannibalism/infanticide and maternal aggression towards pups in laboratory rodents. Laboratory animals 58 (3) (2024)
Elena Fernández-Delgado, Samuel Estirado, Ana B Rodríguez, Francisco Luna-Giles, Emilio Viñuelas Zahı Nos, Javier Espino, José Antonio Pariente
Cytotoxic Effects of New Palladium(II) Complexes with Thiazine or Thiazoline Derivative Ligands in Tumor Cell Lines. Pharmaceutics 15 (2) (2023)
Elena Fernández-Delgado, Samuel Estirado, Ana B Rodríguez, Francisco Luna-Giles, Emilio Viñuelas Zahı Nos, Javier Espino, José Antonio Pariente
Cytotoxic Effects of New Palladium(II) Complexes with Thiazine or Thiazoline Derivative Ligands in Tumor Cell Lines. Pharmaceutics 15 (2) (2023)
Elena Fernández-Delgado, Samuel Estirado, Ana B Rodríguez, Francisco Luna-Giles, Emilio Viñuelas Zahı Nos, Javier Espino, José Antonio Pariente
Cytotoxic Effects of New Palladium(II) Complexes with Thiazine or Thiazoline Derivative Ligands in Tumor Cell Lines. Pharmaceutics 15 (2) (2023)
Elena Fernández-Delgado, Samuel Estirado, Ana B Rodríguez, Francisco Luna-Giles, Emilio Viñuelas Zahı Nos, Javier Espino, José Antonio Pariente
Cytotoxic Effects of New Palladium(II) Complexes with Thiazine or Thiazoline Derivative Ligands in Tumor Cell Lines. Pharmaceutics 15 (2) (2023)